|
1
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhivotovsky B and Orrenius S:
Carcinogenesis and apoptosis: paradigms and paradoxes.
Carcinogenesis. 27:1939–1945. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taylor RC, Cullen SP and Martin SJ:
Apoptosis: controlled demolition at the cellular level. Nat Rev Mol
Cell Biol. 9:231–241. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Srinivasula SM and Ashwell JD: IAPs:
what’s in a name? Mol Cell. 30:123–135. 2008.
|
|
5
|
Kasof GM and Gomes BC: Livin, a novel
inhibitor of apoptosis protein family member. J Biol Chem.
276:3238–3246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vucic D, Stennicke HR, Pisabarro MT, et
al: ML-IAP, a novel inhibitor of apoptosis that is preferentially
expressed in human melanomas. Curr Biol. 10:1359–1366. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin JH, Deng G, Huang Q and Morser J:
KIAP, a novel member of the inhibitor of apoptosis protein family.
Biochem Biophys Res Commun. 279:820–831. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ashhab Y, Alian A, Polliack A, et al: Two
splicing variants of a new inhibitor of apoptosis gene with
different biological properties and tissue distribution pattern.
FEBS Lett. 495:56–60. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tanabe H, Yagihashi A, Tsuji N, et al:
Expression of survivin mRNA and livin mRNA in non-small-cell lung
cancer. Lung Cancer. 46:299–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gazzaniga P, Gradilone A, Giuliani L, et
al: Expression and prognostic significance of Livin, Survivin and
other apoptosis-related genes in the progression of superficial
bladder cancer. Ann Oncol. 14:85–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi J, Hwang YK, Sung KW, et al:
Expression of Livin, an anti-apoptotic protein, is an independent
favorable prognostic factor in childhood acute lymphoblastic
leukemia. Blood. 109:471–47. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiang Y, Yao H, Wang S, et al: Prognostic
value of Survivin and Livin in nasopharyngeal carcinoma.
Laryngoscope. 116:126–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong J, Chen N, Zhou Q, et al: Melanoma
inhibitor of apoptosis protein is expressed differentially in
melanoma and melanocytic naevus, but similarly in primary and
metastatic melanomas. J Clin Pathol. 58:1081–1085. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Chen N, Wang X, et al: Apoptosis
and proliferation markers in diffusely infiltrating astrocytomas:
profiling of 17 molecules. J Neuropathol Exp Neurol. 65:905–913.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nachmias B, Ashhab Y, Bucholtz V, et al:
Caspase-mediated cleavage converts Livin from an antiapoptotic to a
proapoptotic factor: implications for drug-resistant melanoma.
Cancer Res. 63:6340–6349. 2003.PubMed/NCBI
|
|
16
|
Zhou Q, Krebs JF, Snipas SJ, et al:
Interaction of the baculovirus anti-apoptotic protein p35 with
caspases. Specificity, kinetics and characterization of the
caspase/p35 complex. Biochemistry. 37:10757–1065. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vindeløv LL, Christensen IJ and Nissen N:
Standardization of high-resolution flow cytometric DNA analysis by
the simultaneous use of chicken and trout red blood cells as
internal reference standards. Cytometry. 3:328–331. 1983.PubMed/NCBI
|
|
18
|
Yan H, Brouha B, Liu T, et al: Proteolytic
cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially
mediated by a non-canonical caspase. J Dermatol Sci. 43:189–200.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Timmer JC and Salvesen GS: Caspase
substrates. Cell Death Differ. 14:66–72. 2007. View Article : Google Scholar
|
|
20
|
Suzuki Y, Nakabayashi Y and Takahashi R:
Ubiquitin-protein ligase activity of X-linked inhibitor of
apoptosis protein promotes proteasomal degradation of caspase-3 and
enhances its anti-apoptotic effect in Fas-induced cell death. Proc
Natl Acad Sci USA. 98:8662–8667. 2001. View Article : Google Scholar
|
|
21
|
Silke J, Kratina T, Chu D, et al:
Determination of cell survival by RING-mediated regulation of
inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci
USA. 102:16182–16187. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang H, Joazeiro CA, Bonfoco E, et al:
The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein
ligase and promotes in vitro monoubiquitination of caspases 3 and
7. J Biol Chem. 275:26661–26664. 2000.PubMed/NCBI
|
|
23
|
Ma L, Huang Y, Song Z, et al: Livin
promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway.
Cell Death Differ. 13:2079–2088. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vucic D, Franklin MC, Wallweber HJ, et al:
Engineering ML-IAP to produce an extraordinarily potent caspase 9
inhibitor: implications for Smac-dependent anti-apoptotic activity
of ML-IAP. Biochem J. 385:11–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sanna MG, da Silva Correia J, Ducrey O, et
al: IAP suppression of apoptosis involves distinct mechanisms: the
TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol.
22:1754–1766. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nachmias B, Lazar I, Elmalech M, et al:
Subcellular localization determines the delicate balance between
the anti- and proapoptotic activity of Livin. Apoptosis.
12:1129–1142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang QH and Du C: Smac/DIABLO selectively
reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and
livin in HeLa cells. J Biol Chem. 279:16963–16970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crnkovic-Mertens I, Muley T, Meister M, et
al: The anti-apoptotic livin gene is an important determinant for
the apoptotic resistance of non-small cell lung cancer cells. Lung
Cancer. 54:135–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Crnkovic-Mertens I, Bulkescher J, Mensger
C, et al: Isolation of peptides blocking the function of
anti-apoptotic Livin protein. Cell Mol Life Sci. 67:1895–1905.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Crnkovic-Mertens I, Hoppe-Seyler F and
Butz K: Induction of apoptosis in tumor cells by siRNA-mediated
silencing of the livin/ML-IAP/KIAP gene. Oncogene. 22:8330–8336.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang R, Lin F, Wang X, et al: Silencing
Livin gene expression to inhibit proliferation and enhance
chemosensitivity in tumor cells. Cancer Gene Ther. 15:402–412.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie J, Xiong L, Tao X, et al: Antitumor
effects of murine bone marrow-derived dendritic cells infected with
xenogeneic livin alpha recombinant adenoviral vectors against Lewis
lung carcinoma. Lung Cancer. 68:338–345. 2010. View Article : Google Scholar
|
|
33
|
Wang L, Zhang Q, Liu B, et al: Challenge
and promise: roles for Livin in progression and therapy of cancer.
Mol Cancer Ther. 7:3661–3669. 2008. View Article : Google Scholar : PubMed/NCBI
|
